chronic lower back pain

News

Data backs Vertanical's cannabis therapy for back pain

A phase 3 trial of Vertanical's cannabis extract in back pain has been published, and the results bode well for marketing applications under review.

News

Computer-generated image of a human figure with lower back pain radiating in red

After phase 3 hit, Spine seeks path forward for pain drug

The first phase 3 readout with Spine BioPharma's drug candidate for chronic low back pain has proved disappointing.

News

Vertanical's chief executive, Dr Clemens Fischer

Vertanical's cannabis-based painkiller hits target in trials

A cannabis-derived drug developed by Vertanical has shown efficacy in phase 3 for chronic back pain and could reach its first markets soon.

News

Digital health tech for back pain recommended for NHS use

Seven digital health technologies that could help millions of people with lower back pain have been recommended for NHS in draft guidance published by cost-effectiveness o

News

AppliedVR's virtual reality therapy for pain cleared by FDA

A virtual reality system developed by AppliedVR that has been shown in trials to help reduce chronic lower back pain has been approved by the FDA as a prescription digital therapeutic (DTx)

News

Trial finds Orion digital therapeutic helps chronic pain suf...

A digital therapeutic aimed at people with chronic lower back pain based on virtual reality (VR) has shown encouraging results in a clinical trial, helping patients manage the fear of movem

Data backs Vertanical's cannabis therapy for back pain

After phase 3 hit, Spine seeks path forward for pain drug

Vertanical's cannabis-based painkiller hits target in trials

Digital health tech for back pain recommended for NHS use

AppliedVR's virtual reality therapy for pain cleared by FDA

Trial finds Orion digital therapeutic helps chronic pain suf...

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

chronic lower back pain

Editor's Picks